论文部分内容阅读
目的异乐定联合倍他乐克治疗稳定型心绞痛的临床疗效。方法将100例患者随机分成两组,在给予肠溶阿司匹林、麝香保心丸基础上,治疗组加用异乐定及倍他乐克;对照组加用消心痛。6周为一疗程,观察两组疗效。结果治疗组对稳定型心绞痛缓解总有效率为92.0%,对照组为76.0%,治疗组明显优于对照组(P<0.05)。对ECG改善的有效率分别为72.0%和42.0%,均相差显著(P<0.05);且未见明显的不良反应。结论异乐定联合倍他乐克治疗稳定型心绞痛疗效显著,值得临床推广。
Objective To determine the clinical efficacy of combination of metoprolol and metoprolol in the treatment of stable angina pectoris. Methods One hundred patients were randomly divided into two groups. On the basis of enteric-coated aspirin and musk heart-protecting pill, the patients in the treatment group were treated with heterotrimeric and metoprolol, and the control group combined with Xiao-xiao. 6 weeks for a course of treatment, two groups observed efficacy. Results The total effective rate of stable angina pectoris was 92.0% in the treatment group and 76.0% in the control group. The treatment group was significantly better than the control group (P <0.05). The effective rate of ECG improvement was 72.0% and 42.0%, respectively, with significant difference (P <0.05); and no obvious adverse reactions. Conclusion Different combination of Betaloc and Stabilized angina pectoris has significant curative effect and is worthy of clinical promotion.